ArticleBMJ open2022

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0).

Otto Ettala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.